Sweden· SE-20071106000038
Bicalustad 50 mg Filmdragerad tablett
A medicinal product containing bicalutamide, registered in Sweden by STADA Arzneimittel AG.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Bicalutamide
- Manufacturer
- STADA Arzneimittel AG
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20071106000038
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bicalutamide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandBicalutamid ActavisActavis Group PTC ehf
- CzechiaBICALUPLEXTeva Pharmaceuticals CR, s.r.o., Praha
- SpainBICALUTAMIDA ACCORD 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- ItalyBICALUTAMIDE AHCLACCORD HEALTHCARE SLU
- FranceBICALUTAMIDE ACCORD 50 mg, comprimé pelliculéACCORD HEALTHCARE FRANCE
- BelgiumBicalutamide Accord Healthcare 50 mgAccord Healthcare
- NetherlandsBicalutamide 50 PCH, filmomhulde tabletten 50 mgPharmachemie B.V.
- IrelandBicalutamide 50 mg film-coated tabletsAccord Healthcare Ireland Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Androbloc, Bicalutamid +pharma
- Belgium · Bicalutamide Eg, Bicalutamide Sandoz
- Bulgaria · Бикагратис, Бикалутамид Акорд
- Cyprus · Bicalutamide Rafarm, Bikalen
- Czechia · Bicaluplex, Bicalutanorm
- Germany · Bicadex, Bicalut
- Denmark · Bicalustad, Bicalutamid Bluefish
- Estonia · Bicalutamide Accord, Bicalutamide Teva
- Spain · Bicalutamida Accord, Bicalutamida Almus
- Finland · Bicalutamid Orion, Bicalutamide Accord
- France · Bicalutamide Accord, Bicalutamide Almus
- United Kingdom (Northern Ireland) · Bicalutamide, Bicalutamide Accord Healthcare
- Greece · Bicalut, Bicalutamide Rafarm
- Croatia · Bicaprox, Bikalis
- Hungary · Bicalutamide Pharmacenter, Bilutamid
- Ireland · Bicalutamide Accord, Bicalutamide Fair-Med
- Iceland · Bicalutamid Medical, Bicalutamide Accord
- Italy · Bicalutamide Accord, Bicalutamide Ahcl
- Lithuania · Bicalutamide Accord, Bicalutamide Teva
- Luxembourg · Bicalutamide Eg, Bicalutamide Teva
- Latvia · Bicalutamide Accord, Bicalutamide Teva
- Malta · Bicalutamide Pharmacare
- Netherlands · Bicalutamide Accord, Bicalutamide Aurobindo
- Norway · Bicalutamide Accord, Bicalutamide Bluefish
- Poland · Bicalutamide Accord, Binabic
- Portugal · Bicalutamida Accord, Bicalutamida Aurobindo
- Romania · Bicalutamida Accord, Bicalutamidă Accord
- Slovenia · Bikalutamid Accord, Bikalutamid Lek
- Slovakia · Bicagelan, Bicalutamid Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/99d0118b-fb2f-4671-96f4-d00e4ae6336a GET /v1/drugs/99d0118b-fb2f-4671-96f4-d00e4ae6336a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20071106000038",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20071106000038",
"product_doc_link": "https://docetp.mpa.se/LMF/Bicalustad%2050%20mg%20film-coated%20tablet%20SmPC_09001bee807a136a.pdf"
}See everything about bicalutamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.